Ulocuplumab (Anti-CXCR4 / CD184)
Product Specifications
CAS Number
1375830-34-4
Synonyms
BMS 936564; MDX 1338; Anti-Human CXCR4 Recombinant Antibody
Target
CXCR
Applications
GPCR & G Protein
Additionnal Information
Ulocuplumab (Anti-CXCR4 / CD184) is a fully human IgG4 antibody, targeting CXCR4. Ulocuplumab induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic lymphocytic leukemia (CLL) . Ulocuplumab exhibits antitumor activity in established tumors including acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), and multiple myeloma xenograft models. MW: 144.84 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400158-500 1x 500 µL
Cytokeratin 17 (E3), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940158-100 1x 100 µL
Cytokeratin 17 (E3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401076-500 1x 500 µL
Cytokeratin, HMW (KRTH/1076), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470812-500 1x 500 µL
Tyrosinase (OCA1/812), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details